The differential expression of SULT1A1 in tumor tissues versus neighboring normal tissues [35] suggests that expression of SULT1A1 in tumors, but not the germ line SULT1A1 haplotypes, is a more appropriate biomarker to identify responders for therapeutics activated by SULT1A1. Here, SULT1A1 is linked to neoplasm.